ASL 7022

Known as: ASL-7022 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1982-2004
01219822004

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Three inotropic agents, ASL-7022, dobutamine and dopamine, were evaluated for their α-and β-adrenoceptor mediated effects in… (More)
  • figure 1
  • table 1
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
1989
1989
ASL-7022 is a new synthetic catecholamine with alpha and beta adrenoceptor stimulating activity having inotropic selectivity in… (More)
Is this relevant?
1985
1985
The peripheral vascular actions of i.v. administered ASL-7022 were investigated in anesthetized, open-chest dogs and in isolated… (More)
Is this relevant?
1984
1984
Three inotropic agents, ASL-7022, dobutamine and dopamine, were evaluated for their alpha- and beta-adrenoceptor mediated effects… (More)
Is this relevant?
1984
1984
Three selective inotropic agents, ASL-7022, dobutamine and dopamine, were evaluated for their effects at alpha and beta… (More)
Is this relevant?
1983
1983
ASL-7022 is a novel inotropic agent capable of increasing the force of myocardial contraction at doses which produce little… (More)
Is this relevant?
1982
1982
ASL-7022 (2-[3-(3,4-dihydroxy-phenyl)-1-methylethyl]-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) was examined for… (More)
Is this relevant?
1982
1982
The effect of ganglionic blockade (GB, hexamethonium, 10 mg/kg i.v.) upon the inotropic/chronotropic actions of ASL-7022 (2-[2-(3… (More)
Is this relevant?